InsiderClue
Insiders · Profile

Grossman William

Interim Chief Medical Officer at enGene Therapeutics · Chief Medical Officer at Arcus Biosciences. Filing since 10 Oct 2019. CIK 0001730229

ENGN enGene Therapeutics Inc. Interim Chief Medical Officer · 1 trade RCUS Arcus Biosciences, Inc. Chief Medical Officer · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ENGN enGene Therapeutics Inc.
22 Sep 2026
Interim Chief Medical Officer
Bought
5,102
$10.05K
opened
RCUS Arcus Biosciences, Inc.
17 Jun 2021
Chief Medical Officer
Sold, plan not stated
3,891
$92.14K
15.8%
RCUS Arcus Biosciences, Inc.
16 Jun 2021
Chief Medical Officer
Sold, plan not stated
3,174
$76.67K
11.4%
RCUS Arcus Biosciences, Inc.
23 Apr 2021
Chief Medical Officer
Sold, plan not stated
4,133
$129.65K
38.1%
RCUS Arcus Biosciences, Inc.
16 Mar 2021
Chief Medical Officer
Sold, plan not stated
2,127
$74.51K
16.4%
RCUS Arcus Biosciences, Inc.
16 Dec 2020
Chief Medical Officer
Sold, plan not stated
2,117
$66.37K
23.9%
RCUS Arcus Biosciences, Inc.
31 Jul 2020
Chief Medical Officer
Bought
200
$3.94K
50.0%
RCUS Arcus Biosciences, Inc.
14 Oct 2019
Chief Medical Officer
Bought
300
$2.40K
300%
RCUS Arcus Biosciences, Inc.
10 Oct 2019
Chief Medical Officer
Bought
100
$800.00
opened
9 decisions on file.